Skip to main content
. 2020 Feb 18;10:2812. doi: 10.1038/s41598-020-59686-w

Figure 3.

Figure 3

Evaluation of cell viability percentage of liver cancer cell line (Hep G2) post treatment (A) O. glandulosum Desf. HD oil, (B) nanoemulsion of O. glandulosum Desf. oil, and (C) nanocapsules of O. glandulosum Desf. oil compared with reference drug (D) 5-Fu using MTT assay.